Artwork

Content provided by American Academy of Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Hearing Dysfunction with Teprotumumab

24:31
 
Share
 

Manage episode 431832061 series 3349208
Content provided by American Academy of Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

What does hearing dysfunction have to do with an ophthalmology podcast? Listen up and find out as Dr. Drew Carey interviews Dr. Jamie A. Keen and Dr. Erin M. Shriver on the risks of using teprotumumab to hearing function in treatment of thyroid eye disease. From their article “Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab.”

Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab. Keen, Jamie A. et al. Ophthalmology, Volume 131, Issue 1, 30 – 36.

  continue reading

64 episodes

Artwork
iconShare
 
Manage episode 431832061 series 3349208
Content provided by American Academy of Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

What does hearing dysfunction have to do with an ophthalmology podcast? Listen up and find out as Dr. Drew Carey interviews Dr. Jamie A. Keen and Dr. Erin M. Shriver on the risks of using teprotumumab to hearing function in treatment of thyroid eye disease. From their article “Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab.”

Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab. Keen, Jamie A. et al. Ophthalmology, Volume 131, Issue 1, 30 – 36.

  continue reading

64 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide